P. Grey

发表

Characterization of CD4+ CTLs Ex Vivo1

Anthony D. Kelleher, Victor Appay, Laura Papagno, 2002, The Journal of Immunology.

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

D. Cooper, A. Kelleher, J. Zaunders, 2000, AIDS.

Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection

E. Rosenberg, B. Walker, J. Kaldor, 2006, Journal of Virology.

High Viral Fitness during Acute HIV-1 Infection

A. Kelleher, M. Law, D. McPhee, 2010, PloS one.

Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.

D. Cooper, A. Kelleher, K. Petoumenos, 2018, AIDS research and human retroviruses.

Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.

J. Corbeil, D. Richman, S. Little, 2003, The Journal of infectious diseases.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

E. Rosenberg, B. Walker, J. Kaldor, 2005, Blood.

Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.

D. Cooper, J. Zaunders, P. Grey, 2001, The Journal of infectious diseases.

Lipodystrophy following antiretroviral therapy of primary HIV infection.

D. Cooper, M. Law, S. Emery, 2000, AIDS.

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.

D. Cooper, A. Kelleher, J. Zaunders, 1999, The Journal of infectious diseases.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection: Final Results From a Randomized Clinical Trial (Pulse)

J. Kaldor, D. Cooper, A. Kelleher, 2006, Journal of acquired immune deficiency syndromes.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Anne M Johnson, C. Morrison, P. Vanhems, 2017, The Journal of antimicrobial chemotherapy.

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

C. Morrison, P. Vanhems, A. Kamali, 2017, HIV medicine.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.

J. Kahn, F. Hecht, D. Cooper, 2003, AIDS research and human retroviruses.